Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tassone

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Leukemia|November 22, 2017
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myelomaA Gullà, T Hideshima, G Bianchi, et al.
Stem Cells (Dayton, Ohio)|April 29, 1998
Identification by differential display of transcripts regulated during hematopoietic differentiationH M Bond, P Bonelli, M Mesuraca, et al.
Cell Death Discovery|October 19, 2016
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patientsE C Martino, G Misso, P Pastina, et al.
Leukemia|January 15, 2011
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cellsT Calimeri, E Battista, F Conforti, et al.
Leukemia|September 21, 2007
Biological pathways and in vivo antitumor activity induced by Atiprimod in myelomaP Neri, P Tassone, M Shammas, et al.
Leukemia|May 20, 2015
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivoE Morelli, E Leone, M E Gallo Cantafio, et al.
Blood Cancer Journal|January 16, 2016
miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growthM Fulciniti, N Amodio, R L Bandi, et al.
Leukemia|November 29, 2016
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironmentF Fan, M H Bashari, E Morelli, et al.
Blood Cancer Journal|September 10, 2016
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcomeD Ronchetti, M Manzoni, L Agnelli, et al.
Leukemia|November 22, 2017
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cellsC Botta, M Cucè, M R Pitari, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Leukemia|November 22, 2017
Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myelomaA Gullà, T Hideshima, G Bianchi, et al.
Stem Cells (Dayton, Ohio)|April 29, 1998
Identification by differential display of transcripts regulated during hematopoietic differentiationH M Bond, P Bonelli, M Mesuraca, et al.
Cell Death Discovery|October 19, 2016
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patientsE C Martino, G Misso, P Pastina, et al.
Leukemia|January 15, 2011
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cellsT Calimeri, E Battista, F Conforti, et al.
Leukemia|September 21, 2007
Biological pathways and in vivo antitumor activity induced by Atiprimod in myelomaP Neri, P Tassone, M Shammas, et al.
Leukemia|May 20, 2015
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivoE Morelli, E Leone, M E Gallo Cantafio, et al.
Blood Cancer Journal|January 16, 2016
miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growthM Fulciniti, N Amodio, R L Bandi, et al.
Leukemia|November 29, 2016
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironmentF Fan, M H Bashari, E Morelli, et al.
Blood Cancer Journal|September 10, 2016
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcomeD Ronchetti, M Manzoni, L Agnelli, et al.
Leukemia|November 22, 2017
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cellsC Botta, M Cucè, M R Pitari, et al.
Pageof 9